Literature DB >> 9050127

The Maudsley Family Study, II: Endogenous event-related potentials in familial schizophrenia.

S Frangou1, T Sharma, G Alarcon, T Sigmudsson, N Takei, C Binnie, R M Murray.   

Abstract

Auditory event-related potentials (ERPs) were obtained from 33 schizophrenics, from 16 families multiply affected with schizophrenia, 57 of their non-schizophrenic first-degree relatives and 32 unrelated healthy controls. Transmission of schizophrenia in these families appeared unilinear with one parent only transmitting the disorder. Consequently, we were able to identify 10 presumed obligate carriers and study eight of them. Schizophrenic patients showed latency prolongation and amplitude reduction of the N100, N200 and P300 waves compared to controls. Their relatives showed similar abnormalities compared to controls. There was a trend for bimodal distribution of the P300 latency in the relatives, with 20 (35%) of them falling outside two standard deviations of the mean of the controls. These included six of the eight obligate carriers. Our results suggest that ERP abnormalities may serve as markers of genetic vulnerability in schizophrenia and may be useful in genetic linkage studies.

Entities:  

Mesh:

Year:  1997        PMID: 9050127     DOI: 10.1016/S0920-9964(96)00089-8

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  24 in total

Review 1.  Biomarkers for the effects of antipsychotic drugs in healthy volunteers.

Authors:  S J de Visser; J van der Post; M S Pieters; A F Cohen; J M van Gerven
Journal:  Br J Clin Pharmacol       Date:  2001-02       Impact factor: 4.335

2.  Novelty-elicited mismatch negativity in patients with schizophrenia on admission and discharge.

Authors:  I Grzella; B W Müller; R D Oades; S Bender; U Schall; D Zerbin; J Wolstein; G Sartory
Journal:  J Psychiatry Neurosci       Date:  2001-05       Impact factor: 6.186

3.  Associations and Heritability of Auditory Encoding, Gray Matter, and Attention in Schizophrenia.

Authors:  Yu-Han Chen; Breannan Howell; J Christopher Edgar; Mingxiong Huang; Peter Kochunov; Michael A Hunter; Cassandra Wootton; Brett Y Lu; Juan Bustillo; Joseph R Sadek; Gregory A Miller; José M Cañive
Journal:  Schizophr Bull       Date:  2019-06-18       Impact factor: 9.306

4.  A longitudinal study of event related potentials and correlations with psychosocial functioning and clinical features in first episode psychosis patients.

Authors:  Caitlin K Monaghan; Sophie Brickman; Polly Huynh; Dost Öngür; Mei-Hua Hall
Journal:  Int J Psychophysiol       Date:  2019-05-17       Impact factor: 2.997

5.  Clinical high risk and first episode schizophrenia: auditory event-related potentials.

Authors:  Elisabetta C del Re; Kevin M Spencer; Naoya Oribe; Raquelle I Mesholam-Gately; Jill Goldstein; Martha E Shenton; Tracey Petryshen; Larry J Seidman; Robert W McCarley; Margaret A Niznikiewicz
Journal:  Psychiatry Res       Date:  2014-11-29       Impact factor: 3.222

Review 6.  Electrophysiological Endophenotypes for Schizophrenia.

Authors:  Emily M Owens; Peter Bachman; David C Glahn; Carrie E Bearden
Journal:  Harv Rev Psychiatry       Date:  2016 Mar-Apr       Impact factor: 3.732

7.  Abnormal auditory N100 amplitude: a heritable endophenotype in first-degree relatives of schizophrenia probands.

Authors:  Bruce I Turetsky; Tiffany A Greenwood; Ann Olincy; Allen D Radant; David L Braff; Kristin S Cadenhead; Dorcas J Dobie; Robert Freedman; Michael F Green; Raquel E Gur; Ruben C Gur; Gregory A Light; James Mintz; Keith H Nuechterlein; Nicholas J Schork; Larry J Seidman; Larry J Siever; Jeremy M Silverman; William S Stone; Neal R Swerdlow; Debby W Tsuang; Ming T Tsuang; Monica E Calkins
Journal:  Biol Psychiatry       Date:  2008-08-13       Impact factor: 13.382

8.  An auditory processing abnormality specific to liability for schizophrenia.

Authors:  Rachel B Force; Noah C Venables; Scott R Sponheim
Journal:  Schizophr Res       Date:  2008-06-20       Impact factor: 4.939

Review 9.  Neurophysiological biomarkers for drug development in schizophrenia.

Authors:  Daniel C Javitt; Kevin M Spencer; Gunvant K Thaker; Georg Winterer; Mihály Hajós
Journal:  Nat Rev Drug Discov       Date:  2008-01       Impact factor: 84.694

10.  Combining gene expression, demographic and clinical data in modeling disease: a case study of bipolar disorder and schizophrenia.

Authors:  Jan Struyf; Seth Dobrin; David Page
Journal:  BMC Genomics       Date:  2008-11-07       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.